Arcellx, Inc. (ACLX) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $115.07 (—)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 24, 2026 | Michael Yee | UBS | $115.00 | -0.1% |
| Feb 24, 2026 | Market Perform | Leerink Partners | $115.00 | -0.1% |
| Feb 23, 2026 | Cory Kasimov | Evercore ISI | $115.00 | -0.1% |
| Feb 23, 2026 | Emily Bodnar | H.C. Wainwright | $115.00 | -0.1% |
| Feb 12, 2026 | Qize Ding | Redburn Partners | $82.00 | -28.7% |
| Jan 7, 2026 | Michael Yee | UBS | $100.00 | -13.1% |
| Nov 3, 2025 | John Newman | Canaccord Genuity | $130.00 | +13.0% |
| Oct 16, 2025 | Stephen Willey | Stifel Nicolaus | $129.00 | +12.1% |
| Nov 8, 2024 | Biren Amin | Piper Sandler | $115.00 | -0.1% |
| Nov 6, 2024 | Jack Allen | Robert W. Baird | $106.00 | -7.9% |
| Nov 6, 2024 | Emily Bodnar | H.C. Wainwright | $95.00 | -17.4% |
| Oct 29, 2024 | Cory Kasimov | Evercore ISI | $120.00 | +4.3% |
| Oct 18, 2024 | Ben Burnett | Stifel Nicolaus | $122.00 | +6.0% |
| May 31, 2024 | Biren Amin | Piper Sandler | $70.00 | -39.2% |
| May 15, 2024 | Benjamin Burnett | Stifel Nicolaus | $83.00 | -27.9% |
| May 13, 2024 | Cory Kasimov | Evercore ISI | $85.00 | -26.1% |
| Mar 18, 2024 | Gil Blum | Needham | $81.00 | -29.6% |
| Jul 20, 2022 | John Newman | Canaccord Genuity | $32.00 | -72.2% |
Top Analysts Covering ACLX
ACLX vs Sector & Market
| Metric | ACLX | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.67 | 2.24 | 2.41 |
| Analyst Count | 15 | 8 | 18 |
| Target Upside | -2.3% | +1150.3% | +14.9% |
| P/E Ratio | -28.30 | 6.89 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $5M | $6M | $9M | 3 |
| 2026-09-30 | $15M | $18M | $24M | 1 |
| 2026-12-31 | $24M | $29M | $39M | 2 |
| 2027-03-31 | $41M | $48M | $65M | 1 |
| 2027-06-30 | $56M | $66M | $90M | 2 |
| 2027-09-30 | $81M | $96M | $130M | 2 |
| 2027-12-31 | $132M | $157M | $213M | 1 |
| 2028-12-31 | $441M | $446M | $452M | 11 |
| 2029-12-31 | $390M | $743M | $1.31B | 5 |
| 2030-12-31 | $568M | $1.08B | $1.91B | 5 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $-1.28 | $-1.18 | $-1.09 | 3 |
| 2026-09-30 | $-1.56 | $-1.07 | $-0.85 | 1 |
| 2026-12-31 | $-1.48 | $-1.01 | $-0.81 | 1 |
| 2027-03-31 | $-0.93 | $-0.64 | $-0.51 | 1 |
| 2027-06-30 | $-0.71 | $-0.49 | $-0.39 | 1 |
| 2027-09-30 | $-0.28 | $-0.19 | $-0.15 | 1 |
| 2027-12-31 | $0.37 | $0.47 | $0.68 | 1 |
| 2028-12-31 | $-0.57 | $0.39 | $1.43 | 10 |
| 2029-12-31 | $1.48 | $3.87 | $7.74 | 4 |
| 2030-12-31 | $2.84 | $7.42 | $14.82 | 4 |
Frequently Asked Questions
What is the analyst consensus for ACLX?
The consensus among 15 analysts covering Arcellx, Inc. (ACLX) is Hold with an average price target of $112.45.
What is the highest price target for ACLX?
The highest price target for ACLX is $130.00, set by John Newman at Canaccord Genuity on 2025-11-03.
What is the lowest price target for ACLX?
The lowest price target for ACLX is $32.00, set by John Newman at Canaccord Genuity on 2022-07-20.
How many analysts cover ACLX?
15 analysts have issued ratings for Arcellx, Inc. in the past 12 months.
Is ACLX a buy or sell right now?
Based on 15 analyst ratings, ACLX has a consensus rating of Hold (2.67/5) with a -2.3% upside to the consensus target of $112.45.
What are the earnings estimates for ACLX?
Analysts estimate ACLX will report EPS of $-1.18 for the period ending 2026-06-30, with revenue estimated at $6M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.